Caligan Partners LP
26 holdingsFiling period: 2026-06-30Current AUM: $1.73Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | LQDA | Liquidia Corporation | 8.12M | $647.3M | $295.1M | 17.07% | -- | 2026-06-30 |
| 2 | RVMD | Revolution Medicines Inc | 2.21M | $414.6M | $435.1M | 25.17% | +331.9K | 2026-06-30 |
| 3 | ABVX | Abivax SA | 1.56M | $207.6M | $144.2M | 8.34% | +96.0K | 2026-06-30 |
| 4 | PCVX | Vaxcyte Inc | 2.19M | $127.2M | $145.0M | 8.39% | +127.9K | 2026-06-30 |
| 5 | EXEL | Exelixis Inc | 1.55M | $84.5M | $100.0M | 5.79% | -- | 2026-06-30 |
| 6 | TNGX | Tango Therapeutics Inc | 2.50M | $78.2M | $63.1M | 3.65% | +91.3K | 2026-06-30 |
| 7 | AVTX | Avalo Therapeutics Inc | 3.16M | $58.5M | $39.1M | 2.26% | +1.53M | 2026-06-30 |
| 8 | XENE | Xenon Pharmaceuticals Inc | 889.9K | $53.7M | $32.3M | 1.87% | -503,083 | 2026-06-30 |
| 9 | ADMA | Adma Biologics Inc | 6.03M | $50.4M | $67.7M | 3.91% | +968.5K | 2026-06-30 |
| 10 | LBRX | LB Pharmaceuticals Inc | 1.44M | $46.7M | $59.0M | 3.41% | -- | 2026-06-30 |
| 11 | IMCR | Immunocore Hldgs PLC | 1.38M | $43.9M | $45.0M | 2.60% | -- | 2026-06-30 |
| 12 | VRDN | Viridian Therapeutics Inc | 2.19M | $40.3M | $49.2M | 2.85% | -- | 2026-06-30 |
| 13 | VOR | Vor Biopharma Inc | 1.93M | $35.4M | $36.6M | 2.12% | -- | 2026-06-30 |
| 14 | SABS | SAB Biotherapeutics Inc | 7.97M | $31.1M | $22.9M | 1.33% | -- | 2026-06-30 |
| 15 | IVA | Inventiva SA | 8.16M | $30.9M | $26.6M | 1.54% | +3.19M | 2026-06-30 |
| 16 | AURA | Aura Biosciences Inc | 4.30M | $30.5M | $28.2M | 1.63% | +4.07M | 2026-06-30 |
| 17 | TYRA | Tyra Biosciences Inc | 807.0K | $25.8M | $16.5M | 0.96% | -469,982 | 2026-06-30 |
| 18 | IRD | Opus Genetics Inc | 6.08M | $25.0M | $24.4M | 1.41% | +2.1K | 2026-06-30 |
| 19 | ANIK | Anika Therapeutics Inc | 1.44M | $21.0M | $29.3M | 1.70% | -- | 2026-06-30 |
| 20 | SGMT | Sagimet Biosciences Inc | 2.50M | $19.3M | $24.3M | 1.41% | -- | 2026-06-30 |
| 21 | ARTV | Artiva Biotherapeutics Inc | 1.74M | $16.8M | $11.4M | 0.66% | -- | 2026-06-30 |
| 22 | SNSE | Faeth Therapeutics Inc | 629.5K | $15.7M | $15.7M | 0.91% | +503.5K | 2026-06-30 |
| 23 | MBX | Mbx Biosciences Inc | 200.0K | $11.0M | $10.7M | 0.62% | -648,590 | 2026-06-30 |
| 24 | VRCA | Verrica Pharmaceuticals Inc | 923.9K | $5.7M | $3.2M | 0.19% | -- | 2026-06-30 |
| 25 | AGIO | Agios Pharmaceuticals Inc | 90.0K | $3.3M | $3.3M | 0.19% | -- | 2026-06-30 |
← Scroll →
Page 1 of 2